These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 20596663)
1. Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology. Chen D; Chen F; Lu X; Yang X; Xu Z; Pan J; Huang Y; Lin H; Chi P Int J Oncol; 2010 Aug; 37(2):355-65. PubMed ID: 20596663 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology. Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280 [TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer. Ma Y; Zhao M; Zhong J; Shi L; Luo Q; Liu J; Wang J; Yuan X; Huang C J Cell Biochem; 2010 Aug; 110(6):1512-9. PubMed ID: 20524204 [TBL] [Abstract][Full Text] [Related]
4. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627 [TBL] [Abstract][Full Text] [Related]
5. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer. Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759 [TBL] [Abstract][Full Text] [Related]
6. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Kim H; Kang HJ; You KT; Kim SH; Lee KY; Kim TI; Kim C; Song SY; Kim HJ; Lee C; Kim H Proteomics; 2006 Jun; 6(11):3466-76. PubMed ID: 16645984 [TBL] [Abstract][Full Text] [Related]
7. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry. Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392 [TBL] [Abstract][Full Text] [Related]
8. Prohibitin is an important biomarker for nasopharyngeal carcinoma progression and prognosis. Liao Q; Guo X; Li X; Xiong W; Li X; Yang J; Chen P; Zhang W; Yu H; Tang H; Deng M; Liang F; Wu M; Luo Z; Wang R; Zeng X; Zeng Z; Li G Eur J Cancer Prev; 2013 Jan; 22(1):68-76. PubMed ID: 22728421 [TBL] [Abstract][Full Text] [Related]
9. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers. You J; Kao A; Dillon R; Croner LJ; Benz R; Blume JE; Wilcox B J Proteomics; 2018 Sep; 187():80-92. PubMed ID: 29953963 [TBL] [Abstract][Full Text] [Related]
10. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers. Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117 [TBL] [Abstract][Full Text] [Related]
11. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Besson D; Pavageau AH; Valo I; Bourreau A; Bélanger A; Eymerit-Morin C; Moulière A; Chassevent A; Boisdron-Celle M; Morel A; Solassol J; Campone M; Gamelin E; Barré B; Coqueret O; Guette C Mol Cell Proteomics; 2011 Dec; 10(12):M111.009712. PubMed ID: 21986994 [TBL] [Abstract][Full Text] [Related]
12. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry. Bai Y; Wang J; Gao Z; Dai E Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204 [TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues]. Lin MX; Wen ZF; Feng ZY; He D Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002 [TBL] [Abstract][Full Text] [Related]
14. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer. Wu W; Yang P; Feng X; Wang H; Qiu Y; Tian T; He Y; Yu C; Yang J; Ye S; Zhou Y Genes Chromosomes Cancer; 2013 Dec; 52(12):1133-40. PubMed ID: 24123284 [TBL] [Abstract][Full Text] [Related]
15. Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer. Sugihara Y; Taniguchi H; Kushima R; Tsuda H; Kubota D; Ichikawa H; Sakamoto K; Nakamura Y; Tomonaga T; Fujita S; Kondo T J Proteomics; 2012 Sep; 75(17):5342-55. PubMed ID: 22735596 [TBL] [Abstract][Full Text] [Related]
16. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins. Zhao L; Liu L; Wang S; Zhang YF; Yu L; Ding YQ J Cancer Res Clin Oncol; 2007 Oct; 133(10):771-82. PubMed ID: 17503081 [TBL] [Abstract][Full Text] [Related]
17. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma. Wang L; Lin D; Fu Y; Lai M Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829 [TBL] [Abstract][Full Text] [Related]
18. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma. Gheytanchi E; Saeednejad Zanjani L; Ghods R; Abolhasani M; Shahin M; Vafaei S; Naseri M; Fattahi F; Madjd Z J Cancer Res Clin Oncol; 2021 Jun; 147(6):1631-1646. PubMed ID: 33616717 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis. Takahashi H; Wang JP; Zheng HC; Masuda S; Takano Y Histol Histopathol; 2011 Jun; 26(6):663-71. PubMed ID: 21472681 [TBL] [Abstract][Full Text] [Related]